Observational Study on the Clinical Use of Ex Vivo Lung Perfusion (XPS™) for Lung Transplantation

Launched by HANNOVER MEDICAL SCHOOL · Jan 27, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a method called Ex Vivo Lung Perfusion (XPS™) to improve lung transplantation. In this process, lungs are treated outside the body before being transplanted to help doctors assess their quality and suitability for patients in need of a lung transplant. The goal is to collect information about how well this method works and how it affects patient outcomes after the transplant.

To participate in this study, you need to be at least 18 years old and have a lung transplant planned using the XPS™ system. However, if the transplanting surgeon feels that the lungs are not suitable based on their assessment, you may not be eligible. While participating, you can expect to have your data collected and monitored to help researchers understand the effectiveness of this new approach. This trial is currently recruiting participants of all genders, and it aims to gather valuable insights that could improve future lung transplant procedures.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Min Age 18 years
• • Acceptance of the organ using the XPS™ ex vivo lung perfusion system is made by the center based on clinical assessment and visual inspection
• Exclusion Criteria:
• • The usual criteria for the assessment of donors apply
• • The transplanting surgeon is not satisfied with the lung assessment on the XPS™ according to clinical criteria